Randomized controlled trial of bromelain and alpha-lipoic acid in breast conservative surgery

Aim of study is to analyze Bromelain' effects on the most common early complications after BCS (oedema and seroma). From January 2021 to December 2023 a double-blind randomized placebo-controlled trial was performed on 114 candidates for BCS at our Academic Unit. Group A received a supplement of Casperome™-Boswellia Phytosome<sup>®</sup> + Bromelain (CBB) in combination with alpha-lipoic acid + superoxide dismutase + B and D vitamins + centella asiatica. Group B received a supplement of CBB + placebo. Group C received placebo. The therapies were administrated for 30 days. On GEE logistic regression, drugs combination in A seems to be associated with statistical fewer oedema compared with C (P = 0.018 at 1 day and P = 0.002 after 1 month). Comparing B to C, B gained a significative value after 1 month (P = 0.007). On GEE logistic regression, the drugs combination in A has been associated with statistical fewer seroma compared with C (P = 0.009 at 15thpostoperative day and P < 0.001 after 1 month). B vs C reaches significant values 15 day and 1 month after surgery (P = 0.002 and P < 0.001, respectively). The current study is the first analyzing the employment of CBB association with/without neurotrophic agent on prevention of early complications after BCS.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2025-02-10
DOI
https://doi.org/10.1038/s41598-025-86651-2
Citations
1
Primary Topic
Biochemical Acid Research Studies
Type
article
Field-Weighted Citation Impact
1.11
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Randomized controlled trial of bromelain and alpha-lipoic acid in breast conservative surgery

Claudia Angelini, Silvia Gentile, L. Clemente, L. Lapadula et al.
1 citations
Scientific Reports
Biochemical Acid Research Studies
1.11
article

Randomized controlled trial of bromelain and alpha-lipoic acid in breast conservative surgery

Claudia Angelini, Silvia Gentile, L. Clemente, L. Lapadula, Giuseppe Giudice, Francesco Paolo Prete, M. Lambo, Antonio Carrieri, Giuseppe Massimiliano De Luca, Francesca Iuele, Tiziana Grassi, Alessandro Pasculli, Alessandro Nitti, W. Lavermicocca, Filomena Puntillo, Valentina Ronghi, Mario Testini, Fernando Palma, Pasquale Tedeschi, Gabriella Serio, Mariateresa Giglio, Marco Moschetta, M. Telegrafo, Nicoletta Resta, Angela Gurrado, Marco Favetta, Valentina Lorusso, Mauro G. Mastropasqua, Michele Maruccia, Lucia Ilaria Sgaramella, Luigia Stefania Stucci, Michele Piombino, Concetta Caporusso, E. Lacalendola, Aaron L. Magno, Rossella Elia, Patrizia Dicillo, Giuseppe Rubini, Luigi Macchia, Corinna Altini, A Pisani, E Poli, Antonio Giorgio, M. Amendolagine, C. Deleo, V. Deruvo, G. L. Digiulio, S. Mastrorillo, F. Solfrizzo
article en
1 citations

Abstract

Aim of study is to analyze Bromelain' effects on the most common early complications after BCS (oedema and seroma). From January 2021 to December 2023 a double-blind randomized placebo-controlled trial was performed on 114 candidates for BCS at our Academic Unit. Group A received a supplement of Casperome™-Boswellia Phytosome<sup>®</sup> + Bromelain (CBB) in combination with alpha-lipoic acid + superoxide dismutase + B and D vitamins + centella asiatica. Group B received a supplement of CBB + placebo. Group C received placebo. The therapies were administrated for 30 days. On GEE logistic regression, drugs combination in A seems to be associated with statistical fewer oedema compared with C (P = 0.018 at 1 day and P = 0.002 after 1 month). Comparing B to C, B gained a significative value after 1 month (P = 0.007). On GEE logistic regression, the drugs combination in A has been associated with statistical fewer seroma compared with C (P = 0.009 at 15thpostoperative day and P < 0.001 after 1 month). B vs C reaches significant values 15 day and 1 month after surgery (P = 0.002 and P < 0.001, respectively). The current study is the first analyzing the employment of CBB association with/without neurotrophic agent on prevention of early complications after BCS.

Scientific ReportsVol. 15(1)
Istituto Tumori Bari (IT), Istituti di Ricovero e Cura a Carattere Scientifico (IT), University of Bari Aldo Moro (IT)
Good health and well-being
Openalex Percentile: Top 25%
Biochemical Acid Research Studies
1.11
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.